Atlas Trials

Q32 Bio Inc.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Q32 Bio Inc.

RecordFirmDate
A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA) (NCT06018428)Q32 Bio Inc.2023-09-12
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD) (NCT05509023)Q32 Bio Inc.2022-09-30
Single and Multiple Ascending Dose Study of ADX-914 in Healthy Adult Volunteers (NCT04485481)Q32 Bio Inc.2020-09-08

Track Q32 Bio Inc. automatically

Every clearance here is in the API, with alerts when new ones post.